Palatin Technologies
PTN
$0.31
Share price
10.04%
Change (1 day)
-43.64%
Change (1 year)
Revenue for Palatin Technologies (PTN)
Revenue in 2022 (TTM): $1.95 M
According to Palatin Technologies's latest financial reports the company's current revenue (TTM) is $0.74 M. In 2021 the company made a revenue of $0.74 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Palatin Technologies from 2005 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $1.95 M | 161.73% |
| 2021 | $0.74 M | |
| 2017 | $0.08 B | |
| 2012 | $0.04 M | -82.26% |
| 2011 | $0.25 M | -94.31% |
| 2010 | $4.49 M | -77.9% |
| 2009 | $0.02 B | 445.4% |
| 2008 | $3.72 M | -75.87% |
| 2007 | $0.01 B | -17.37% |
| 2006 | $0.01 B | 10.8% |
| 2005 | $0.01 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $94.88 B | 12,725,972.89% | 🇺🇸 USA |
 Astrazeneca AZN | $41.48 B | 5,564,471.94% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $1.20 B | 161,859.67% | 🇺🇸 USA |
 MediciNova MNOV | $0.01 B | 1,246.75% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.26 B | 35,802.87% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | $0.19 B | 25,766.60% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.22 B | 30,225.29% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $1.15 M | 55.56% | 🇺🇸 USA |
 Ardelyx ARDX | $3.98 M | 434.23% | 🇺🇸 USA |